Hong Kong,China
Premiumsupplier
Semaglutide CAS NO.910463-68-2
- FOB Price: USD: 20.00-50.00 /Metric Ton Get Latest Price
- Min.Order: 1 box
- Payment Terms: T/T,Other
- Available Specifications:
100(1-50)Metric Ton100(50-100)Metric Ton
- Product Details
Keywords
- Weightloss peptides Semaglutide
- High purity 99% Semaglutide
- Factory Price Retatrutide
Quick Details
- ProName: Semaglutide Customized bottle caps, sp...
- CasNo: 910463-68-2
- Molecular Formula: C187H291N45O59
- Appearance: Bottled, boxed
- Application: Medicinal
- DeliveryTime: 20days
- ProductionCapacity: 500 box/Day
- Purity: 99.9%
- Storage: refrigerate
- LimitNum: 1 box
Superiority
Semaglutide
- Blood sugar lowering effect
- Semaglutide, as a new GLP-1 analog, has a significant and lasting blood sugar lowering effect. Clinical studies have shown that Semaglutide is superior to other GLP-1 analogs in reducing glycated hemoglobin (HbA1c) levels and has a longer duration of action, which enables patients to better achieve blood sugar control and reduce the risk of complications.
- Weight loss effect
- Obesity is an important risk factor for type 2 diabetes. Semaglutide can effectively reduce weight while lowering blood sugar. Clinical studies have shown that Semaglutide's weight loss effect is superior to other GLP-1 analogs, which helps improve patients' quality of life and reduce the risk of cardiovascular disease.
- Improving blood lipid profile
- Dyslipidemia in diabetic patients is an important risk factor for cardiovascular complications. Semaglutide can significantly improve blood lipid profile, reduce triglyceride and low-density lipoprotein cholesterol levels, and increase high-density lipoprotein cholesterol levels while lowering blood sugar and weight, thereby reducing the risk of cardiovascular disease.
- Widely applicable population
- Semaglutide is suitable for a wide range of people. Regardless of whether the patient has complications such as obesity and dyslipidemia, Semaglutide can exert significant therapeutic effects. In addition, Semaglutide does not rely on insulin secretion, so it is suitable for diabetic patients with poor pancreatic function.
- Good safety
- Semaglutide has good safety and fewer adverse reactions. Clinical studies have shown that the use of Semaglutide is associated with adverse reactions such as gastrointestinal discomfort, nausea, and diarrhea, but the degree is relatively mild and most of them occur in the early stage of treatment. As the treatment time increases, the adverse reactions gradually decrease. In addition, Semaglutide does not increase the risk of hypoglycemia, which is of great significance to diabetic patients.